Santen Pharmaceutical Co., Ltd. (SZD0)
Munich
Closed
Aug 24, 2026
Day's Range
10.4052 wk Range
8.30Overview - SZD0 - Santen Pharmaceutical Co., Ltd.
Key Statistics
Valuation
Enterprise Value
-408.96M
P/E (Trailing)
‪17.04‬
PEG Ratio
‪2.12‬
Price / Sales (TTM)
‪0.01‬
Price / Book
‪2.10‬
EV / EBITDA
‪-1.16‬
Profitability
Profit Margin
‪13.25%‬
Operating Margin
‪11.77%‬
Return on Assets
‪7.09%‬
Return on Equity
‪13.42%‬
Ownership
Shares Outstanding
321.68M
Float
314.54M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
50-Day Avg
‪10.90‬
200-Day Avg
‪9.74‬
Dividends
Payout Ratio
‪32.34%‬
Frequency
Semi-Annual
Market Cap - SZD0 - Santen Pharmaceutical Co., Ltd.
Peers - SZD0 - Santen Pharmaceutical Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on Munich.
- SZD0MunichSanten Pharmaceutical Co., Ltd.3.34BMarket Cap+13.94%52-week change16.77P/E (Trailing)‪13.25%‬Profit Margin
- CUP0MunichChugai Pharmaceutical Co., Ltd.62.53BMarket Cap+6.84%52-week change24.68P/E (Trailing)‪35.10%‬Profit Margin
- ON4MunichOno Pharmaceutical Co. Ltd.6.21BMarket Cap+28.19%52-week change16.54P/E (Trailing)‪15.11%‬Profit Margin
Profile Summary - SZD0 - Santen Pharmaceutical Co., Ltd.
About
Santen Pharmaceutical Co., Ltd. is a distinguished entity within the pharmaceutical industry, primarily focused on ophthalmology. As a leading player in the production and development of eye care products, Santen's purpose is to innovate and provide comprehensive treatments for various eye conditions. The company's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
